Javascript must be enabled to continue!
Neonatal mortality attributable to preterm births associated with maternal HIV infection in sub-Saharan Africa
View through CrossRef
Objectives:
We aimed to estimate the burden of neonatal mortality attributable to preterm births associated with maternal HIV infection in sub-Saharan Africa in 1990–2020.
Design:
Modelling study.
Methods:
Estimates of the excess risk of preterm birth among pregnant women with HIV (WWH) in sub-Saharan Africa in 1990–2020 were obtained from a systematic review and meta-analysis. Data on preterm birth, neonatal mortality, and deaths <1 year directly caused by HIV/AIDS were obtained from the Global Burden of Disease Study 2021. Information on antiretroviral treatment received by WWH in sub-Saharan Africa in 1990–2020 were obtained from UNAIDS. These data were used to estimate neonatal mortality due to HIV-attributable preterm birth in countries in sub-Saharan Africa in 1990–2020.
Results:
In 1990–2020, there were an estimated 85 288 (95% confidence interval 53 147–136 921) neonatal deaths due to HIV-attributable preterm births in sub-Saharan Africa. The number of neonatal deaths due to HIV-attributable preterm births in sub-Saharan Africa increased during the 1990s, before decreasing in the 2000s, reaching a nadir around 2012, and increasing again within the last decade to levels in 2020 that were similar to their highest levels in the early 2000s. In 2020, neonatal deaths from HIV-attributable preterm birth exceeded direct HIV/AIDS infant deaths <1 year in sub-Saharan Africa, and by 5–25-fold in countries with a high HIV prevalence.
Conclusions:
Neonatal deaths due to HIV-attributable preterm birth are increasing and now exceed direct HIV/AIDS infant deaths <1 year in sub-Saharan Africa, particularly in countries with a high HIV prevalence.
Title: Neonatal mortality attributable to preterm births associated with maternal HIV infection in sub-Saharan Africa
Description:
Objectives:
We aimed to estimate the burden of neonatal mortality attributable to preterm births associated with maternal HIV infection in sub-Saharan Africa in 1990–2020.
Design:
Modelling study.
Methods:
Estimates of the excess risk of preterm birth among pregnant women with HIV (WWH) in sub-Saharan Africa in 1990–2020 were obtained from a systematic review and meta-analysis.
Data on preterm birth, neonatal mortality, and deaths <1 year directly caused by HIV/AIDS were obtained from the Global Burden of Disease Study 2021.
Information on antiretroviral treatment received by WWH in sub-Saharan Africa in 1990–2020 were obtained from UNAIDS.
These data were used to estimate neonatal mortality due to HIV-attributable preterm birth in countries in sub-Saharan Africa in 1990–2020.
Results:
In 1990–2020, there were an estimated 85 288 (95% confidence interval 53 147–136 921) neonatal deaths due to HIV-attributable preterm births in sub-Saharan Africa.
The number of neonatal deaths due to HIV-attributable preterm births in sub-Saharan Africa increased during the 1990s, before decreasing in the 2000s, reaching a nadir around 2012, and increasing again within the last decade to levels in 2020 that were similar to their highest levels in the early 2000s.
In 2020, neonatal deaths from HIV-attributable preterm birth exceeded direct HIV/AIDS infant deaths <1 year in sub-Saharan Africa, and by 5–25-fold in countries with a high HIV prevalence.
Conclusions:
Neonatal deaths due to HIV-attributable preterm birth are increasing and now exceed direct HIV/AIDS infant deaths <1 year in sub-Saharan Africa, particularly in countries with a high HIV prevalence.
Related Results
HIV WGS - 400bp Amplicon Tiling - Oxford Nanopore Technology Protocol v1
HIV WGS - 400bp Amplicon Tiling - Oxford Nanopore Technology Protocol v1
OSPHL in collaboration with APHL, will evaluate the performance of the Oxford Nanopore Technology sequencers for HIV genome sequencing using a modified protocol of the ARTIC amplic...
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
Abstract
Introduction
Human immunodeficiency virus (HIV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) surface glycoproteins, including shared epitope motifs, sho...
Capítulo 6 – HIV-AIDS, como tratar, o que fazer e o que não fazer durante o tratamento?
Capítulo 6 – HIV-AIDS, como tratar, o que fazer e o que não fazer durante o tratamento?
A infecção pelo vírus do HIV pode ocorrer de diversas maneiras, tendo sua principal forma a via sexual por meio do sexo desprotegido. O vírus do HIV fica em um período de incubação...
US Birth Weight/Gestational Age-Specific Neonatal Mortality: 1995–1997 Rates for Whites, Hispanics, and Blacks
US Birth Weight/Gestational Age-Specific Neonatal Mortality: 1995–1997 Rates for Whites, Hispanics, and Blacks
Objective. In recent years, gains in neonatal survival have been most evident among very low birth weight, preterm, and low birth weight (LBW) infants. Most of the improvement in n...
Cardiovascular Malformations Among Preterm Infants
Cardiovascular Malformations Among Preterm Infants
Objective. Preterm birth and cardiovascular malformations are the 2 most common causes of neonatal and infant death, but there are no published population-based reports on the rela...
Classification and heterogeneity of preterm birth
Classification and heterogeneity of preterm birth
Three main conditions explain preterm birth: medically indicated (iatrogenic) preterm birth (25%; 18.7–35.2%), preterm premature rupture of membranes (PPROM) (25%; 7.1–51.2%) and s...
Preterm Births Attributable to Criteria Air Pollutant Exposure in Bangladesh During 2015–2019
Preterm Births Attributable to Criteria Air Pollutant Exposure in Bangladesh During 2015–2019
Criteria air pollutant exposure has always been a major factor that negatively impacts human health through different pathways. One of the critical concerns is adverse birth outcom...
Laboratory-based Evaluation of Wondfo HIV1/2 Rapid Test Kits in the Gambia, December 2020
Laboratory-based Evaluation of Wondfo HIV1/2 Rapid Test Kits in the Gambia, December 2020
Background: HIV rapid diagnosis in The Gambia is mainly done using Determine HIV-1/2 and First Response HIV 1.2.0 or SD Bioline HIV-1/2 3.0 for screening and sero-typing of HIV res...

